PEPE, MARTINO
 Distribuzione geografica
Continente #
NA - Nord America 4.862
AS - Asia 1.790
EU - Europa 1.274
SA - Sud America 404
AF - Africa 67
OC - Oceania 2
AN - Antartide 1
Totale 8.400
Nazione #
US - Stati Uniti d'America 4.790
SG - Singapore 872
BR - Brasile 335
CN - Cina 331
IT - Italia 280
HK - Hong Kong 255
DE - Germania 246
RU - Federazione Russa 219
VN - Vietnam 119
FR - Francia 110
FI - Finlandia 102
SE - Svezia 99
GB - Regno Unito 93
CA - Canada 45
ID - Indonesia 45
IN - India 38
AR - Argentina 34
CI - Costa d'Avorio 34
NL - Olanda 23
AT - Austria 21
MX - Messico 18
TR - Turchia 18
IQ - Iraq 16
JP - Giappone 16
PK - Pakistan 16
ZA - Sudafrica 14
BD - Bangladesh 13
BE - Belgio 12
PL - Polonia 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
ES - Italia 10
LT - Lituania 9
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
CO - Colombia 5
VE - Venezuela 5
CH - Svizzera 4
IE - Irlanda 4
IR - Iran 4
JO - Giordania 4
PE - Perù 4
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
KE - Kenya 3
MY - Malesia 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
KH - Cambogia 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
TJ - Tagikistan 1
UY - Uruguay 1
YE - Yemen 1
Totale 8.400
Città #
Dallas 2.626
Singapore 457
Ashburn 370
Hong Kong 252
Fairfield 223
Munich 161
Beijing 151
Chandler 133
Woodbridge 119
Houston 98
New York 86
Bari 78
Seattle 78
Cambridge 73
Los Angeles 72
Helsinki 68
Nyköping 65
Wilmington 59
Ann Arbor 47
Jakarta 41
Buffalo 40
Ho Chi Minh City 37
Abidjan 34
Marseille 33
Santa Clara 32
Hanoi 30
Boardman 26
São Paulo 25
Chicago 22
Xi'an 22
Turku 20
Lawrence 19
London 19
Roxbury 19
Nanjing 16
Brooklyn 15
Milan 15
Montreal 15
Jacksonville 14
Moscow 14
Frankfurt am Main 13
Poplar 13
Brussels 12
Rio de Janeiro 12
Denver 11
Des Moines 11
Falkenstein 11
Karachi 11
Nuremberg 11
Secaucus 11
Tokyo 11
Ankara 10
Atlanta 10
Da Nang 10
Naples 10
Salvador 10
San Diego 10
Stockholm 10
Johannesburg 9
Manchester 9
Phoenix 9
Toronto 9
Baghdad 8
Dong Ket 8
Paris 8
Rome 8
San Francisco 8
Vienna 8
Warsaw 8
Bisceglie 7
Brasília 7
Charlotte 7
Chennai 7
Dearborn 7
Düsseldorf 7
Foggia 7
Inglewood 7
Princeton 7
Shenyang 7
The Dalles 7
Barletta 6
Brno 6
Campinas 6
Chaozhou 6
Council Bluffs 6
Dongguan 6
Mexico City 6
Orem 6
San Jose 6
Tashkent 6
Belo Horizonte 5
Buenos Aires 5
Columbus 5
Grottaglie 5
Haiphong 5
Porto Alegre 5
Portsmouth 5
Shenzhen 5
Amman 4
Asunción 4
Totale 6.198
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 365
Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies 290
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis 251
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation 245
Giant Cardiac Fibroma in a Completely Asymptomatic Teenager 219
Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices 212
No Reflow-phenomenon: from Current State of the Art to Future Perspectives 200
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess? 200
Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction 193
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 190
A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient 189
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents 186
Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis 183
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 176
Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race 171
How to Approach a Spontaneous Coronary Artery Dissection: An Up-To-Date 166
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 166
Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia 158
'Broken-heart' syndrome: ventricular septal perforation in a takotsubo cardiomyopathy 157
STEMI and NSTEMI ACS in a 30-Year-Old Patient: An Extremely Rare Complication of a Left Atrial Myxoma. 157
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction 148
Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients 146
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk 144
Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo. 140
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy 128
Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias 126
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 122
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure 111
Th2-dependent cytokine release in patients treated with coronary angioplasty 110
Aortic coarctation: guidelines mismatch across the ocean 102
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 101
Fractional flow reserve and intravascular scan as part of the coronary fistulas diagnostic process: Future perspectives 91
Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy 83
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 82
Corrigendum to "A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient" 81
Aortic valve fibroelastoma presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA): a case report and review of the literature 80
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 79
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 76
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 74
Infiammazione Th17 dipendente e attivazione metallo-proteasica dopo angioplastica coronarica. 72
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 69
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those <85 Years 69
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories 69
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 68
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 67
Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis 66
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 66
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 66
Percutaneous exclusion of ascending aorta pseudoaneurysms: still an interventional challenge? 64
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 63
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 63
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 62
A concealed case of takotsubo syndrome as consequence of ab ingestis episode in a revascularized patient 60
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]) 59
Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry 53
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart 53
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient 53
Clinical use of cangrelor: a real-world multicenter experience from South Italy 53
Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. 53
Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"? 52
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions 51
Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm? 48
Antithrombotic Therapy for Vascular Disease and Intervention: The Best Is Yet to Come? 48
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes 45
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 45
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry) 43
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation 42
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis 40
Transcatheter aortic valve implantation in patients with age ≤70 years: experience from two leading structural heart disease centers 40
Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center 40
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 40
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry 37
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry 37
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score 37
Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices 37
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway 37
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 36
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study 35
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 34
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). 34
Underlying heart diseases and acute COVID-19 outcomes 33
The best way to transcatheter aortic valve implantation: from standard to new approaches 31
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases 30
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections 30
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis 29
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry 29
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 29
Minimally invasive approaches to primary cardiac tumors: A systematic review and meta-analysis 28
The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case Series 25
Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices 25
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) 24
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis 24
Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study 21
Unsupervised Machine Learning with Cluster Analysis in Patients Discharged after an Acute Coronary Syndrome: Insights from a 23,270-Patient Study 21
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry 19
Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip 18
A 25-year-long journey into interventional cardiology: looking back, and rushing forward 18
Acute Hyperglycemia-Induced Injury in Myocardial Infarction 18
Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study 17
Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst? 16
Totale 8.689
Categoria #
all - tutte 31.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 11 9 39 23 39 13 24
2021/2022192 22 4 2 4 10 26 16 11 14 18 25 40
2022/2023471 32 44 21 22 31 45 2 54 86 76 39 19
2023/2024319 21 50 22 26 35 80 8 13 10 12 9 33
2024/20251.925 93 20 80 130 78 148 289 176 98 107 221 485
2025/20264.866 514 224 3.014 469 475 170 0 0 0 0 0 0
Totale 8.830